Prior to treatment with FGF-23 antibodies, moderate chronic kidney disease (CKD) rats with normal serum phosphate levels had high UFE phosphate levels and low 1,25(OH)2-vitamin D3 levels. The gene discussed is FGF23; the disease is chronic kidney disease.